Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.

Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant, Nataliya V Uboha, Dustin Deming, Midhun Malla, Anup Kasi, Kelsey Klute, Kristen R Spencer, Arvind Dasari, Van K Morris, Gregory Botta, Andrew M Lowy

March 2025 JCO Precis Oncol

Synopsis of Social media discussions

Several posts express enthusiasm about the publication, with remarks like 'Glad to see this finally come out,' indicating strong interest and perceived importance. Communications demonstrate positive tones and focus on the publication's role in advancing cancer research, but lack detailed critical analysis, reflecting a moderate level of engagement and impact expectation.

A
Agreement
 Moderate agreement

Most discussions express support for the importance of the publication, highlighting its potential significance in the field, as seen in posts praising the publication and noting its role in advancing cancer research.

I
Interest
 High level of interest

Discussions demonstrate high curiosity and relevance, with comments showing enthusiasm about the topic being finally introduced and its implications for clinical trials.

E
Engagement
 Moderate level of engagement

Posts generally reference the content and context of the paper, but do not deeply analyze the methodologies or detailed implications, indicating moderate engagement.

I
Impact
 Moderate level of impact

While some mentions suggest the publication could influence future research and clinical practices, overall perception indicates moderate impact rather than transformative change, evidenced by language that calls it 'Finally coming out' and mentions of su

Social Mentions

YouTube

1 Videos

Bluesky

1 Posts

Twitter

29 Posts

Metrics

Video Views

93

Total Likes

47

Extended Reach

119,004

Social Features

31

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Incorporating Circulating Tumor DNA Testing into Clinical Trials in Gastrointestinal Cancers

Incorporating Circulating Tumor DNA Testing into Clinical Trials in Gastrointestinal Cancers

Dr Philip discusses how circulating tumor DNA testing can be integrated into clinical trials for GI cancers. The focus is on using ctDNA in early-phase trials to evaluate treatment effectiveness and its potential as a noninvasive biomarker.

ASCO Podcasts

June 18, 2025

93 views

  • Lakshmi Rajdev
    @luckydoc2 (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 2, 2025

    9

  • Roberta Horgan
    @HorganRoberta (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 1, 2025

    9

  • Jessica Castrillon Lal
    @CastrillonJess (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 1, 2025

    9

  • Alan Tan
    @alantanmd (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 1, 2025

    9

  • Jman4956
    @jman4956 (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 1, 2025

    9

  • SWOG Cancer Research Network
    @SWOG (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 1, 2025

    9

  • NRG Oncology
    @NRGonc (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 1, 2025

    9

  • Alok Khorana, MD
    @aakonc (Twitter)

    RT @CathyEngMD: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https:…
    view full post

    April 1, 2025

    9

  • CathyEngMD
    @cathyengmd.bsky.social (Bluesky)

    Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… pubmed.ncbi.nlm.nih.gov/40048671/ Glad to see this finally come out from the #NCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #ctDNA #CancerResearch #Cancer
    view full post

    April 1, 2025

  • Dr. Cathy Eng
    @CathyEngMD (Twitter)

    Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https://t.co/a3Ih35lp3Y Glad to see this finally come out from the @theNCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #ctDNA #CancerResearch #Cancer
    view full post

    April 1, 2025

    22

    9

  • Dr. Cathy Eng
    @CathyEngMD (Twitter)

    Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… https://t.co/a3Ih35lp3Y Glad to see this finally come out from the @theNCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #CancerResearch #Cancer
    view full post

    April 1, 2025

  • Mostafa Faisal
    @MostafaFaisal14 (Twitter)

    RT @JCOPO_ASCO: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Onco…
    view full post

    March 28, 2025

    3

  • Rafeh Naqash, MD, FASCO
    @thenasheffect (Twitter)

    RT @JCOPO_ASCO: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Onco…
    view full post

    March 28, 2025

    3

  • Davide Ciardiello
    @DCiardiello (Twitter)

    RT @JCOPO_ASCO: Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Onco…
    view full post

    March 28, 2025

    3

  • JCO Precision Oncology
    @JCOPO_ASCO (Twitter)

    Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group. Read more: https://t.co/qsFvTl9vEp
    view full post

    March 28, 2025

    6

    3

  • Alejandro Rosales
    @HpbNicaragua (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 15, 2025

    14

  • Filip Bednar
    @Fil_Bednar (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 15, 2025

    14

  • Michael Shusterman, MD
    @guildsman (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 15, 2025

    14

  • Santhosh Ambika
    @RenoHemonc (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 15, 2025

    14

  • Hasan Alam
    @DrHasanAlam (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Lavanya Yohanathan
    @LYohanathan (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Ricardo Carvalho
    @rcarvalhoonco (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Anish Jay Jain MD
    @AnishJayJain (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Umme H. Faisal, MBBS
    @stethospeaks (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Syed A. Ahmad
    @SyedAAhmad5 (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Joao Fogacci
    @FogacciJoao (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Layla Haddad
    @InnovateLungs (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Lakshmi Rajdev
    @luckydoc2 (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • Bowen Wang
    @NU_JEANSS (Twitter)

    RT @MDAkhilChawla:
    view full post

    March 14, 2025

    14

  • AKHIL CHAWLA
    @MDAkhilChawla (Twitter)


    view full post

    March 14, 2025

    19

    14

Abstract Synopsis

  • The National Cancer Institute's GI Oncology Circulating Tumor DNA Working Group is exploring how circulating tumor DNA (ctDNA) can be used in clinical trials for gastrointestinal (GI) cancers, but more research is needed to define its role as a primary endpoint.
  • The group recommends using ctDNA mainly in early-phase (phase II) trials to assess treatment effectiveness and as a noninvasive method for drug development, but its role in late-stage trials as a main outcome still requires more data.
  • To effectively include ctDNA in trials, researchers need to consider specific disease biological factors, optimize trial design, and conduct prospective studies to confirm whether ctDNA can reliably predict survival outcomes like progression-free or overall survival.]